Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuroendocrine Tumor Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Everolimus
1.2.3 Sunitinib
1.2.4 Lu-Dotatate
1.2.5 Lanreotide
1.2.6 Octreotide
1.3 Market by Application
1.3.1 Global Neuroendocrine Tumor Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neuroendocrine Tumor Treatment Market Perspective (2018-2033)
2.2 Neuroendocrine Tumor Treatment Growth Trends by Region
2.2.1 Global Neuroendocrine Tumor Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Neuroendocrine Tumor Treatment Historic Market Size by Region (2018-2023)
2.2.3 Neuroendocrine Tumor Treatment Forecasted Market Size by Region (2024-2033)
2.3 Neuroendocrine Tumor Treatment Market Dynamics
2.3.1 Neuroendocrine Tumor Treatment Industry Trends
2.3.2 Neuroendocrine Tumor Treatment Market Drivers
2.3.3 Neuroendocrine Tumor Treatment Market Challenges
2.3.4 Neuroendocrine Tumor Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuroendocrine Tumor Treatment Players by Revenue
3.1.1 Global Top Neuroendocrine Tumor Treatment Players by Revenue (2018-2023)
3.1.2 Global Neuroendocrine Tumor Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Neuroendocrine Tumor Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neuroendocrine Tumor Treatment Revenue
3.4 Global Neuroendocrine Tumor Treatment Market Concentration Ratio
3.4.1 Global Neuroendocrine Tumor Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuroendocrine Tumor Treatment Revenue in 2022
3.5 Neuroendocrine Tumor Treatment Key Players Head office and Area Served
3.6 Key Players Neuroendocrine Tumor Treatment Product Solution and Service
3.7 Date of Enter into Neuroendocrine Tumor Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuroendocrine Tumor Treatment Breakdown Data by Type
4.1 Global Neuroendocrine Tumor Treatment Historic Market Size by Type (2018-2023)
4.2 Global Neuroendocrine Tumor Treatment Forecasted Market Size by Type (2024-2033)
5 Neuroendocrine Tumor Treatment Breakdown Data by Application
5.1 Global Neuroendocrine Tumor Treatment Historic Market Size by Application (2018-2023)
5.2 Global Neuroendocrine Tumor Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Neuroendocrine Tumor Treatment Market Size (2018-2033)
6.2 North America Neuroendocrine Tumor Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Neuroendocrine Tumor Treatment Market Size by Country (2018-2023)
6.4 North America Neuroendocrine Tumor Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neuroendocrine Tumor Treatment Market Size (2018-2033)
7.2 Europe Neuroendocrine Tumor Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Neuroendocrine Tumor Treatment Market Size by Country (2018-2023)
7.4 Europe Neuroendocrine Tumor Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neuroendocrine Tumor Treatment Market Size (2018-2033)
8.2 Asia-Pacific Neuroendocrine Tumor Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Neuroendocrine Tumor Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Neuroendocrine Tumor Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neuroendocrine Tumor Treatment Market Size (2018-2033)
9.2 Latin America Neuroendocrine Tumor Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Neuroendocrine Tumor Treatment Market Size by Country (2018-2023)
9.4 Latin America Neuroendocrine Tumor Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neuroendocrine Tumor Treatment Market Size (2018-2033)
10.2 Middle East & Africa Neuroendocrine Tumor Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Neuroendocrine Tumor Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Neuroendocrine Tumor Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Exelixis, Inc.
11.1.1 Exelixis, Inc. Company Detail
11.1.2 Exelixis, Inc. Business Overview
11.1.3 Exelixis, Inc. Neuroendocrine Tumor Treatment Introduction
11.1.4 Exelixis, Inc. Revenue in Neuroendocrine Tumor Treatment Business (2018-2023)
11.1.5 Exelixis, Inc. Recent Development
11.2 Advanced Accelerator Applications
11.2.1 Advanced Accelerator Applications Company Detail
11.2.2 Advanced Accelerator Applications Business Overview
11.2.3 Advanced Accelerator Applications Neuroendocrine Tumor Treatment Introduction
11.2.4 Advanced Accelerator Applications Revenue in Neuroendocrine Tumor Treatment Business (2018-2023)
11.2.5 Advanced Accelerator Applications Recent Development
11.3 Dauntless Pharmaceuticals, Inc.
11.3.1 Dauntless Pharmaceuticals, Inc. Company Detail
11.3.2 Dauntless Pharmaceuticals, Inc. Business Overview
11.3.3 Dauntless Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Introduction
11.3.4 Dauntless Pharmaceuticals, Inc. Revenue in Neuroendocrine Tumor Treatment Business (2018-2023)
11.3.5 Dauntless Pharmaceuticals, Inc. Recent Development
11.4 Hutchinson Medipharma Limited
11.4.1 Hutchinson Medipharma Limited Company Detail
11.4.2 Hutchinson Medipharma Limited Business Overview
11.4.3 Hutchinson Medipharma Limited Neuroendocrine Tumor Treatment Introduction
11.4.4 Hutchinson Medipharma Limited Revenue in Neuroendocrine Tumor Treatment Business (2018-2023)
11.4.5 Hutchinson Medipharma Limited Recent Development
11.5 Ispen
11.5.1 Ispen Company Detail
11.5.2 Ispen Business Overview
11.5.3 Ispen Neuroendocrine Tumor Treatment Introduction
11.5.4 Ispen Revenue in Neuroendocrine Tumor Treatment Business (2018-2023)
11.5.5 Ispen Recent Development
11.6 Novartis AG
11.6.1 Novartis AG Company Detail
11.6.2 Novartis AG Business Overview
11.6.3 Novartis AG Neuroendocrine Tumor Treatment Introduction
11.6.4 Novartis AG Revenue in Neuroendocrine Tumor Treatment Business (2018-2023)
11.6.5 Novartis AG Recent Development
11.7 Progenics Pharmaceuticals, Inc.
11.7.1 Progenics Pharmaceuticals, Inc. Company Detail
11.7.2 Progenics Pharmaceuticals, Inc. Business Overview
11.7.3 Progenics Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Introduction
11.7.4 Progenics Pharmaceuticals, Inc. Revenue in Neuroendocrine Tumor Treatment Business (2018-2023)
11.7.5 Progenics Pharmaceuticals, Inc. Recent Development
11.8 Tarveda Therapeutics
11.8.1 Tarveda Therapeutics Company Detail
11.8.2 Tarveda Therapeutics Business Overview
11.8.3 Tarveda Therapeutics Neuroendocrine Tumor Treatment Introduction
11.8.4 Tarveda Therapeutics Revenue in Neuroendocrine Tumor Treatment Business (2018-2023)
11.8.5 Tarveda Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Neuroendocrine Tumor Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Everolimus
Table 3. Key Players of Sunitinib
Table 4. Key Players of Lu-Dotatate
Table 5. Key Players of Lanreotide
Table 6. Key Players of Octreotide
Table 7. Global Neuroendocrine Tumor Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Neuroendocrine Tumor Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Neuroendocrine Tumor Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Neuroendocrine Tumor Treatment Market Share by Region (2018-2023)
Table 11. Global Neuroendocrine Tumor Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Neuroendocrine Tumor Treatment Market Share by Region (2024-2033)
Table 13. Neuroendocrine Tumor Treatment Market Trends
Table 14. Neuroendocrine Tumor Treatment Market Drivers
Table 15. Neuroendocrine Tumor Treatment Market Challenges
Table 16. Neuroendocrine Tumor Treatment Market Restraints
Table 17. Global Neuroendocrine Tumor Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Neuroendocrine Tumor Treatment Market Share by Players (2018-2023)
Table 19. Global Top Neuroendocrine Tumor Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroendocrine Tumor Treatment as of 2022)
Table 20. Ranking of Global Top Neuroendocrine Tumor Treatment Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Neuroendocrine Tumor Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Neuroendocrine Tumor Treatment Product Solution and Service
Table 24. Date of Enter into Neuroendocrine Tumor Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Neuroendocrine Tumor Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Neuroendocrine Tumor Treatment Revenue Market Share by Type (2018-2023)
Table 28. Global Neuroendocrine Tumor Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Neuroendocrine Tumor Treatment Revenue Market Share by Type (2024-2033)
Table 30. Global Neuroendocrine Tumor Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Neuroendocrine Tumor Treatment Revenue Market Share by Application (2018-2023)
Table 32. Global Neuroendocrine Tumor Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Neuroendocrine Tumor Treatment Revenue Market Share by Application (2024-2033)
Table 34. North America Neuroendocrine Tumor Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Neuroendocrine Tumor Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Neuroendocrine Tumor Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Neuroendocrine Tumor Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Neuroendocrine Tumor Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Neuroendocrine Tumor Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Neuroendocrine Tumor Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Neuroendocrine Tumor Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Neuroendocrine Tumor Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Neuroendocrine Tumor Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Neuroendocrine Tumor Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Neuroendocrine Tumor Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Neuroendocrine Tumor Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Neuroendocrine Tumor Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Neuroendocrine Tumor Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 49. Exelixis, Inc. Company Detail
Table 50. Exelixis, Inc. Business Overview
Table 51. Exelixis, Inc. Neuroendocrine Tumor Treatment Product
Table 52. Exelixis, Inc. Revenue in Neuroendocrine Tumor Treatment Business (2018-2023) & (US$ Million)
Table 53. Exelixis, Inc. Recent Development
Table 54. Advanced Accelerator Applications Company Detail
Table 55. Advanced Accelerator Applications Business Overview
Table 56. Advanced Accelerator Applications Neuroendocrine Tumor Treatment Product
Table 57. Advanced Accelerator Applications Revenue in Neuroendocrine Tumor Treatment Business (2018-2023) & (US$ Million)
Table 58. Advanced Accelerator Applications Recent Development
Table 59. Dauntless Pharmaceuticals, Inc. Company Detail
Table 60. Dauntless Pharmaceuticals, Inc. Business Overview
Table 61. Dauntless Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Product
Table 62. Dauntless Pharmaceuticals, Inc. Revenue in Neuroendocrine Tumor Treatment Business (2018-2023) & (US$ Million)
Table 63. Dauntless Pharmaceuticals, Inc. Recent Development
Table 64. Hutchinson Medipharma Limited Company Detail
Table 65. Hutchinson Medipharma Limited Business Overview
Table 66. Hutchinson Medipharma Limited Neuroendocrine Tumor Treatment Product
Table 67. Hutchinson Medipharma Limited Revenue in Neuroendocrine Tumor Treatment Business (2018-2023) & (US$ Million)
Table 68. Hutchinson Medipharma Limited Recent Development
Table 69. Ispen Company Detail
Table 70. Ispen Business Overview
Table 71. Ispen Neuroendocrine Tumor Treatment Product
Table 72. Ispen Revenue in Neuroendocrine Tumor Treatment Business (2018-2023) & (US$ Million)
Table 73. Ispen Recent Development
Table 74. Novartis AG Company Detail
Table 75. Novartis AG Business Overview
Table 76. Novartis AG Neuroendocrine Tumor Treatment Product
Table 77. Novartis AG Revenue in Neuroendocrine Tumor Treatment Business (2018-2023) & (US$ Million)
Table 78. Novartis AG Recent Development
Table 79. Progenics Pharmaceuticals, Inc. Company Detail
Table 80. Progenics Pharmaceuticals, Inc. Business Overview
Table 81. Progenics Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Product
Table 82. Progenics Pharmaceuticals, Inc. Revenue in Neuroendocrine Tumor Treatment Business (2018-2023) & (US$ Million)
Table 83. Progenics Pharmaceuticals, Inc. Recent Development
Table 84. Tarveda Therapeutics Company Detail
Table 85. Tarveda Therapeutics Business Overview
Table 86. Tarveda Therapeutics Neuroendocrine Tumor Treatment Product
Table 87. Tarveda Therapeutics Revenue in Neuroendocrine Tumor Treatment Business (2018-2023) & (US$ Million)
Table 88. Tarveda Therapeutics Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuroendocrine Tumor Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Neuroendocrine Tumor Treatment Market Share by Type: 2022 VS 2033
Figure 3. Everolimus Features
Figure 4. Sunitinib Features
Figure 5. Lu-Dotatate Features
Figure 6. Lanreotide Features
Figure 7. Octreotide Features
Figure 8. Global Neuroendocrine Tumor Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Neuroendocrine Tumor Treatment Market Share by Application: 2022 VS 2033
Figure 10. Hospitals Case Studies
Figure 11. Clinic Case Studies
Figure 12. Others Case Studies
Figure 13. Neuroendocrine Tumor Treatment Report Years Considered
Figure 14. Global Neuroendocrine Tumor Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Neuroendocrine Tumor Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Neuroendocrine Tumor Treatment Market Share by Region: 2022 VS 2033
Figure 17. Global Neuroendocrine Tumor Treatment Market Share by Players in 2022
Figure 18. Global Top Neuroendocrine Tumor Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroendocrine Tumor Treatment as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Neuroendocrine Tumor Treatment Revenue in 2022
Figure 20. North America Neuroendocrine Tumor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Neuroendocrine Tumor Treatment Market Share by Country (2018-2033)
Figure 22. United States Neuroendocrine Tumor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Neuroendocrine Tumor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Neuroendocrine Tumor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Neuroendocrine Tumor Treatment Market Share by Country (2018-2033)
Figure 26. Germany Neuroendocrine Tumor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Neuroendocrine Tumor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Neuroendocrine Tumor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Neuroendocrine Tumor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Neuroendocrine Tumor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Neuroendocrine Tumor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Neuroendocrine Tumor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Neuroendocrine Tumor Treatment Market Share by Region (2018-2033)
Figure 34. China Neuroendocrine Tumor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Neuroendocrine Tumor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Neuroendocrine Tumor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Neuroendocrine Tumor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Neuroendocrine Tumor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Neuroendocrine Tumor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Neuroendocrine Tumor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Neuroendocrine Tumor Treatment Market Share by Country (2018-2033)
Figure 42. Mexico Neuroendocrine Tumor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Neuroendocrine Tumor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Neuroendocrine Tumor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Neuroendocrine Tumor Treatment Market Share by Country (2018-2033)
Figure 46. Turkey Neuroendocrine Tumor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Neuroendocrine Tumor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Exelixis, Inc. Revenue Growth Rate in Neuroendocrine Tumor Treatment Business (2018-2023)
Figure 49. Advanced Accelerator Applications Revenue Growth Rate in Neuroendocrine Tumor Treatment Business (2018-2023)
Figure 50. Dauntless Pharmaceuticals, Inc. Revenue Growth Rate in Neuroendocrine Tumor Treatment Business (2018-2023)
Figure 51. Hutchinson Medipharma Limited Revenue Growth Rate in Neuroendocrine Tumor Treatment Business (2018-2023)
Figure 52. Ispen Revenue Growth Rate in Neuroendocrine Tumor Treatment Business (2018-2023)
Figure 53. Novartis AG Revenue Growth Rate in Neuroendocrine Tumor Treatment Business (2018-2023)
Figure 54. Progenics Pharmaceuticals, Inc. Revenue Growth Rate in Neuroendocrine Tumor Treatment Business (2018-2023)
Figure 55. Tarveda Therapeutics Revenue Growth Rate in Neuroendocrine Tumor Treatment Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed